Medical imaging and radiology
Aidoc
Clinical AI platform for radiology and enterprise imaging workflows.
Last updated: June 5, 2026
Back to directoryCureMetrix medical AI product profile
Mammography AI company with FDA-cleared cmTriage worklist-prioritization software and investigational or region-specific breast-screening tools.
Medical imaging and radiology
Best fit
Breast imaging programs evaluating suspicious-case prioritization for 2D screening mammography while keeping radiologists responsible for interpretation.
- Primary use case
- AI-assisted mammography worklist triage and breast-screening workflow prioritization
- Audience
- Breast imaging centers, radiology groups, mammography programs, and imaging AI governance teams
- Risk level
- High
- Pricing signal
- Enterprise imaging pricing; request current product, region, and deployment terms.
- Official sources
- 3 official sources
Compare within workflow: Medical imaging and radiology · comparison shortlist · source index
Regulatory, privacy, evidence, and workflow lens
Product-specific review. These product-specific signals summarize what the cited sources imply before treating CureMetrix as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Verify cmTriage's FDA-cleared notification-only intended use and do not generalize it to diagnosis, DBT, cmAssist, or any region-specific product without separate clearance review. |
|---|---|
| Privacy | Review DICOM routing, cloud processing, hospital-network integration, metadata handling, retention, access controls, and contract terms before routing mammography studies. |
| Evidence | Evaluate local breast-density mix, scanner workflow, suspicious-case prioritization, recall impact, and radiologist performance rather than relying only on vendor benchmark claims. |
| Workflow | Best treated as breast-imaging worklist prioritization that supports standard radiologist interpretation, with monitoring for alert fatigue and missed suspicious cases. |
Where CureMetrix fits
CureMetrix describes FDA-cleared cmTriage for mammography worklist triage and separate cmAssist CAD materials; the FDA 510(k) database lists cmTriage as radiological computer-assisted prioritization software for lesions under K183285.
Not for: Autonomous breast-cancer diagnosis, unsupported mammography modalities, or using investigational cmAssist claims as if they were cleared for U.S. clinical use.
What to verify before using CureMetrix
- Whether the exact CureMetrix module is cmTriage, cmAssist, or another breast-imaging workflow.
- FDA 510(k) K183285 intended use, modality, notification-only status, and any local regulatory limits.
- PACS/worklist integration, DICOM routing, cloud processing, PHI handling, and whether images or metadata leave the facility.
- Local sensitivity, specificity, recall impact, prioritization effect, radiologist workload, and false-positive or false-negative monitoring.
Source links
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
- curemetrix.com / solution-summary
- curemetrix.com / cm-triage-3
- www.accessdata.fda.gov / scripts / cdrh
Related medical AI products
Medical imaging and radiology
Viz.ai
AI-powered care coordination platform with imaging-driven alerts across therapeutic areas.
Medical imaging and radiology
Ferrum Health
Clinical AI governance and deployment platform for health systems adopting multiple imaging or clinical AI models.
Medical imaging and radiology
Blackford Platform
Enterprise medical imaging AI platform for evaluating, deploying, routing, and monitoring multiple radiology AI applications.